Perkins Capital Management Inc Lowers stake in LeMaitre Vascular Inc (LMAT)

LeMaitre Vascular Inc (LMAT) : Perkins Capital Management Inc reduced its stake in LeMaitre Vascular Inc by 0.21% during the most recent quarter end. The investment management company now holds a total of 145,898 shares of LeMaitre Vascular Inc which is valued at $2,430,661 after selling 304 shares in LeMaitre Vascular Inc , the firm said in a disclosure report filed with the SEC on Apr 18, 2016.LeMaitre Vascular Inc makes up approximately 2.89% of Perkins Capital Management Inc’s portfolio.

LeMaitre Vascular Inc opened for trading at $16.4 and hit $16.84 on the upside on Friday, eventually ending the session at $16.66, with a gain of 1.83% or 0.3 points. The heightened volatility saw the trading volume jump to 59,398 shares. Company has a market cap of $306 M.

Other Hedge Funds, Including , Acadian Asset Management boosted its stake in LMAT in the latest quarter, The investment management firm added 56,631 additional shares and now holds a total of 184,245 shares of LeMaitre Vascular Inc which is valued at $2,931,338. LeMaitre Vascular Inc makes up approx 0.01% of Acadian Asset Management’s portfolio. Skylands Capital sold out all of its stake in LMAT during the most recent quarter. The investment firm sold 16,150 shares of LMAT which is valued $256,947. Creative Planning sold out all of its stake in LMAT during the most recent quarter. The investment firm sold 200 shares of LMAT which is valued $3,072.

Many Wall Street Analysts have commented on LeMaitre Vascular Inc. Company shares were Reiterated by Barrington Research on Feb 25, 2016 to “Outperform”, Firm has raised the Price Target to $ 15.50 from a previous price target of $14 .LeMaitre Vascular Inc was Initiated by Sidoti to “Neutral” on Jan 20, 2016.

LeMaitre Vascular Inc. is a provider of medical devices for the treatment of peripheral vascular disease. The Company and its subsidiaries develop manufacture and market medical devices and implants used primarily in the field of vascular surgery. The Company’s product lines include valvulotomes balloon catheters carotid shunts biologic patches biologic grafts radiopaque marking tape anastomotic clips remote endarterectomy devices laparoscopic cholecystectomy devices vascular grafts angioscopes and powered phlebectomy devices. The Company develops manufactures and markets vascular devices to address the needs of vascular surgeons. Its portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart including the Expandable LeMaitre Valvulotome the Pruitt F3 Carotid Shunt VascuTape Radiopaque Tape and the XenoSure biologic patch.

Leave a Reply

LeMaitre Vascular Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on LeMaitre Vascular Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.